[1]CurrentPatentAssignee:MERCK&COINC-US2008/58347,2008,A1Locationinpatent:Page/Pagecolumn37
[1]CurrentPatentAssignee:EUBULUSBIOTHERAPEUTICS-CN111018857,2020,ALocationinpatent:Paragraph0217;0245-0247;0250
[1]CurrentPatentAssignee:EUBULUSBIOTHERAPEUTICS-CN111018857,2020,ALocationinpatent:Paragraph0217;0236-0238;0241
Title: Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance.
Journal: Journal of molecular biology 20170217
Title: A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120615
Title: Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.
Journal: Cancer research 20110601
Title: Aurora kinase inhibitors as anti-cancer therapy.
Journal: Anti-cancer drugs 20100401
Title: MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel.
Journal: Molecular cancer therapeutics 20100101
Title: Shimomura T, et al. MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel. Mol Cancer Ther. 2010 Jan;9(1):157-66.
